---
figid: PMC10537735__pharmaceutics-15-02248-g007
pmcid: PMC10537735
image_filename: pharmaceutics-15-02248-g007.jpg
figure_link: /pmc/articles/PMC10537735/figure/pharmaceutics-15-02248-f007/
number: Figure 7
figure_title: ''
caption: Regulatory effect of liposomal CRE-SD on p65 phosphorylation after incorporating
  JSH23. The Western blots and p-p65/total p65 ratio after subjecting 20 ng/mL RANKL-stimulated
  RAW 264.7 cells to 20 µg/mL liposomal CRE-SD and JSH23 are shown. Statistical significance
  of the difference between the samples treated with 20 µg/mL liposomal CRE-SD and
  JSH23 and the samples treated with 20 µg/mL liposomal CRE-SD is denoted as * p <
  0.05, n = 3.
article_title: Modified Curcuminoid-Rich Extract Liposomal CRE-SDInhibits Osteoclastogenesis
  via the Canonical NF-κB Signaling Pathway.
citation: Sompot Jantarawong, et al. Pharmaceutics. 2023 Sep;15(9):2248.
year: '2023'

doi: 10.3390/pharmaceutics15092248
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- curcuminoid
- liposomal CRE-SD
- osteoclastogenesis
- RANKL-stimulated RAW 264.7 macrophage
- canonical NF-κB signaling pathway

---
